Pediatrics, Johns Hopkins University, Baltimore, MD, USA.
Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Pediatr Transplant. 2021 Feb;25(1):e13849. doi: 10.1111/petr.13849. Epub 2020 Oct 18.
It is well-recognized that adolescence and early adulthood are a high-risk period for non-adherence with treatment regimens in solid organ transplant recipients, leading to high rates of rejection and graft loss (Transplantation, 92, 2011, 1237; Pediatr Transplant, 9, 2005, 381; Transplantation, 77, 2004, 769). Preventing medication non-adherence is the holy grail of transplant adolescent care. If we can determine how best to support our patients in taking their daily medications as prescribed, we can improve long-term health, reduce need for re-transplantation, and reduce healthcare costs. In the last few years, several studies have provided us with additional insights into potentially effective interventions and have highlighted existing gaps in knowledge. This article reviews recent literature published over the last 5 years on the topic of adherence in transplant recipients, highlighting insights and opportunities to promote adherence at the individual patient level, family level, healthcare system level, and community level. Above all, the recent work that is highlighted suggests that adherence interventions for prevention and treatment must be multifaceted, individualized, and longitudinal to be effective.
众所周知,青少年和成年早期是实体器官移植受者不遵守治疗方案的高风险期,导致排斥反应和移植物丢失的发生率很高(《移植》,92,2011,1237;《儿科移植》,9,2005,381;《移植》,77,2004,769)。预防用药不依从是移植青少年护理的圣杯。如果我们能够确定如何最好地支持患者按规定服用日常药物,我们就可以改善长期健康状况,减少再次移植的需要,并降低医疗保健成本。在过去的几年中,有几项研究为我们提供了有关潜在有效干预措施的更多见解,并突出了知识方面的现有差距。本文回顾了过去 5 年来在移植受者依从性主题上发表的最新文献,强调了在个体患者层面、家庭层面、医疗系统层面和社区层面促进依从性的见解和机会。最重要的是,所强调的最近的工作表明,预防和治疗的依从性干预措施必须是多方面的、个体化的和纵向的,才能有效。